Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice

Archives of Dermatological Research

Volumn 288, Issue 8, 1996, Pages 492-494

  Kemeny L ^a   Trach, V ^b   Dobozy, A ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Basotherm GmbH   (Germany)

Author keywords

Croton oil; Dithranol; DNFB; PAF antagonist; Ultraviolet radiation

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; APAFANT; CROTON OIL; DITHRANOL; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; DRUG EFFICACY; EAR; EDEMA; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLERGY; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET B RADIATION;

ANIMALS; AZEPINES; DERMATITIS, ALLERGIC CONTACT; GELS; MICE; MICE, INBRED STRAINS; PLATELET ACTIVATING FACTOR; RADIODERMATITIS; TRIAZOLES; ULTRAVIOLET RAYS;

EID: 0029835183     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050090     Document Type: Article

References (16)

1. Archer CB, Page CP, Morley J, MacDonald DM (1985) Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. Br J Dermatol 112:285-290
2. Au B, Williams TJ, Collins PD (1994) Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet-activating factor as an autocrine modulator. J Immunol 152:5411-5419
3. Braquett P, Touqui L, Shen TY, Vargafting BB (1987) Perspectives in platelet-activating factor research. Pharmacol Rev 39:97-145
4. Calignano A, Cirino G, Meli R, Persico P (1988) Isolation and identification of platelet activating factor in UV-irradiated guinea-pig skin. J Pharmacol Methods 19:89-91
5. Casal-Stenzel J, Muacevic G, Weber K-H (1987) Pharmacological actions of WEB 2086, a new specific antagonist of platelet-activating factor. J Pharmacol Exp Ther 241:974-981
6. Csató M, Czarnetzki BM (1988) Effect of BN 52021, a platelet activating factor antagonist, on experimental murine contact dermatitis. Br J Dermatol 118:475-480
7. Gomez-Cambronero J, Wang E, Johnson G, Huang C-K, Sha'afi RI (1991) Platelet-activating factor induces tyrosine phosphorylation in human neutrophils. J Biol Chem 266:6240-6245
8. Grandel KE, Farr RS, Wanderer AA, Eisenstadt TC, Wassermann SI (1985) Association of platelet activating factor with primary acquired cold urticaria. N Engl J Med 313:405-409
9. Hunyadi J, Kenderessy SzA, Duda E, Braquet P, Dobozy A (1993) Platelet-activating factor antagonist (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells. Mol Immunol 30:517-519
10. Kemény L, Csató M, Dobozy A (1989) Pharmacological studies in dithranol-induced dermatitis in mice. Arch Dermatol Res 281:362-365
11. Kemény L, Ruzicka T, Braun-Falco O (1990) Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol 3:1-20
12. Mallet AI, Cunningham FM (1985) Structural identification of platelet activating factor in psoriatic scale. Biochem Biophys Res Commun 126:192-198
13. O'Flaherty JT, Nishihira J (1987) Arachidonate metabolites, platelet activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. J Immunol 138: 1889-1895
14. Pignol B, Hénane S, Mencia-Huena J-M (1988) Effect of platelet-activating factor and its specific receptor antagonist, BN 52021 (Ginkgolide B), on interleukin I (ILI) release and synthesis by rat spleen adherent monocytes. In: Braquet P (ed) Ginkgolides - chemistry, biology, pharmacology and clinical perspectives, vol 1. JR Prous, Barcelona, pp 703-712
15. Pignol B, Rola-Plesczynski M, Mencia-Huerta J-M (1988) Effect of the specific platelet-activating factor antagonist, BN 52 020 and BN 52021 on interleukin 2 production by human lymphocytes. In: Braquet P (ed) Ginkgolides - chemistry, biology, pharmacology and clinical perspectives, vol 1. JR Prous, Barcelona, pp 713-718
16. Shukla SD (1992) Platelet-activating factor receptor and signal transduction mechanisms. FASEB J 6:2296-2301